128 related articles for article (PubMed ID: 29608546)
1. Postdiagnostic Calcium Channel Blocker Use and Breast Cancer Mortality: A Population-based Cohort Study.
Busby J; Mills K; Zhang SD; Liberante FG; Cardwell CR
Epidemiology; 2018 May; 29(3):407-413. PubMed ID: 29608546
[TBL] [Abstract][Full Text] [Related]
2. Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD).
Grimaldi-Bensouda L; Klungel O; Kurz X; de Groot MC; Maciel Afonso AS; de Bruin ML; Reynolds R; Rossignol M
BMJ Open; 2016 Jan; 6(1):e009147. PubMed ID: 26747033
[TBL] [Abstract][Full Text] [Related]
3. Digoxin use after diagnosis of breast cancer and survival: a population-based cohort study.
Karasneh RA; Murray LJ; Mc Menamin ÚC; Hughes CM; Cardwell CR
Breast Cancer Res Treat; 2015 Jun; 151(3):661-9. PubMed ID: 25975954
[TBL] [Abstract][Full Text] [Related]
4. Association between calcium channel blockers and breast cancer: a meta-analysis of observational studies.
Chen Q; Zhang Q; Zhong F; Guo S; Jin Z; Shi W; Chen C; He J
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):711-8. PubMed ID: 24829113
[TBL] [Abstract][Full Text] [Related]
5. Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older Women.
Raebel MA; Zeng C; Cheetham TC; Smith DH; Feigelson HS; Carroll NM; Goddard K; Tavel HM; Boudreau DM; Shetterly S; Xu S
Am J Epidemiol; 2017 Feb; 185(4):264-273. PubMed ID: 28186527
[TBL] [Abstract][Full Text] [Related]
6. Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study.
Busby J; Mills K; Zhang SD; Liberante FG; Cardwell CR
Breast Cancer Res; 2018 Jan; 20(1):4. PubMed ID: 29351761
[TBL] [Abstract][Full Text] [Related]
7. Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients.
Hicks BM; Murray LJ; Hughes C; Cardwell CR
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):830-40. PubMed ID: 26017274
[TBL] [Abstract][Full Text] [Related]
8. Statin use after diagnosis of breast cancer and survival: a population-based cohort study.
Cardwell CR; Hicks BM; Hughes C; Murray LJ
Epidemiology; 2015 Jan; 26(1):68-78. PubMed ID: 25304447
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group.
Braun S; Boyko V; Behar S; Reicher-Reiss H; Laniado S; Kaplinsky E; Goldbourt U
J Am Coll Cardiol; 1998 Mar; 31(4):804-8. PubMed ID: 9525550
[TBL] [Abstract][Full Text] [Related]
10. Calcium channel blockers and the incidence of breast and prostate cancer: A meta-analysis.
Thakur AA; Wang X; Garcia-Betancourt MM; Forse RA
J Clin Pharm Ther; 2018 Aug; 43(4):519-529. PubMed ID: 29656432
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel blockers and cardiac mortality in the treatment of hypertension: a report from the Department of Health Hypertension Care Computing Project (DHCCP).
Bulpitt CJ; Palmer AJ; Beevers DG; Coles EC; Ledingham JG; Petrie JC; Webster J
J Hum Hypertens; 1997 Apr; 11(4):205-11. PubMed ID: 9185024
[TBL] [Abstract][Full Text] [Related]
12. Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study.
Azoulay L; Soldera S; Yin H; Bouganim N
Epidemiology; 2016 Jul; 27(4):594-601. PubMed ID: 27031042
[TBL] [Abstract][Full Text] [Related]
13. Impact of preadmission treatment with calcium channel blockers or beta blockers on short-term mortality after stroke: a nationwide cohort study.
Sundbøll J; Schmidt M; Horváth-Puhó E; Christiansen CF; Pedersen L; Bøtker HE; Sørensen HT
BMC Neurol; 2015 Mar; 15():24. PubMed ID: 25884780
[TBL] [Abstract][Full Text] [Related]
14. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women.
Fitzpatrick AL; Daling JR; Furberg CD; Kronmal RA; Weissfeld JL
Cancer; 1997 Oct; 80(8):1438-47. PubMed ID: 9338468
[TBL] [Abstract][Full Text] [Related]
15. Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort.
Cardwell CR; Coleman HG; Murray LJ; Entschladen F; Powe DG
Int J Epidemiol; 2013 Dec; 42(6):1852-61. PubMed ID: 24536096
[TBL] [Abstract][Full Text] [Related]
16. Use of clopidogrel and calcium channel blockers and risk of major adverse cardiovascular events.
Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
Eur J Clin Invest; 2012 Mar; 42(3):266-74. PubMed ID: 21834799
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer.
Meier CR; Derby LE; Jick SS; Jick H
Arch Intern Med; 2000 Feb; 160(3):349-53. PubMed ID: 10668837
[TBL] [Abstract][Full Text] [Related]
18. Statin use after colorectal cancer diagnosis and survival: a population-based cohort study.
Cardwell CR; Hicks BM; Hughes C; Murray LJ
J Clin Oncol; 2014 Oct; 32(28):3177-83. PubMed ID: 25092779
[TBL] [Abstract][Full Text] [Related]
19. Protective Association Between Calcium Channel Blocker Use and Breast Cancer Recurrence in Postsurgical Women: A Population-Based Case-Control Study in Taiwan.
Shih JH; Kao LT; Chung CH; Liao GS; Fann LY; Chien WC; Li IH
J Clin Pharmacol; 2020 Jun; 60(6):785-792. PubMed ID: 32020656
[TBL] [Abstract][Full Text] [Related]
20. Calcium channel blockers and breast cancer incidence: An updated systematic review and meta-analysis of the evidence.
Wright CM; Moorin RE; Chowdhury EK; Stricker BH; Reid CM; Saunders CM; Hughes JD
Cancer Epidemiol; 2017 Oct; 50(Pt A):113-124. PubMed ID: 28866282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
